References
- Brasso K, Ingimarsdottir IJ, Thomassen L, Friis S, Iversen P. [Prostate cancer in Denmark 1943–2002]. Ugeskr Laeger 2007; 169: 129–32
- Varenhorst E, Garmo H, Holmberg L, Adolfsson J, Damber JE, Hellstrom M, et al. The National Prostate Cancer Register in Sweden 1998–2002: trends in incidence, treatment and survival. Scand J Urol Nephrol 2005; 39: 117–23
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74–108
- Makarov DV, Trock BJ, Humphreys EB, Mangold LA, Walsh PC, Epstein JI, et al. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. Urology 2007; 69: 1095–101
- Gancarczyk KJ, Wu H, McLeod DG, Kane C, Kusuda L, Lance R, et al. Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomograms. Urology 2003; 61: 589–95
- Freedland SJ, Terris MK, Csathy GS, Kane CJ, Amling CL, Presti JC, Jr, et al. Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen. J Urol 2004; 171: 2215–20
- Tarjan M, Tot T. Prediction of extracapsular extension of prostate cancer based on systematic core biopsies. Scand J Urol Nephrol 2006; 40: 459–64
- Freedland SJ, Aronson WJ, Csathy GS, Kane CJ, Amling CL, Presti JC, Jr, et al. Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database. Urology 2003; 61: 742–7
- Graefen M, Augustin H, Karakiewicz PI, Hammerer PG, Haese A, Palisaar J, et al. Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables. Eur Urol 2003;43:6–10; Discussion.
- Eskicorapci SY, Karabulut E, Turkeri L, Baltaci S, Cal C, Toktas G, et al. Validation of 2001 Partin tables in Turkey: a multicenter study. Eur Urol 2005; 47: 185–9